PHARMACOECONOMIC EVLUATION OF 5-ASA APPLICATION IN LIGHT AND MEDIUM GRAVE DISSEMINATED (RECURRING) ULCERATIVE COLITIS

PHARMACOECONOMIC EVLUATION OF 5-ASA APPLICATION IN LIGHT AND MEDIUM GRAVE DISSEMINATED (RECURRING) ULCERATIVE COLITIS

Inflammatory bowel diseases are chronic relapsing immune-mediated diseases affecting the gastrointestinal tract. The goal of therapy of ulcerative colitis (one of the IBD variants) is the achievement and maintenance of steroid-free remission, prevention of UC complications, prevention of surgeries a...

Full description

Bibliographic Details
Main Author: P. A. Balunov
Format: Article
Language:Russian
Published: Remedium Group LLC 2017-11-01
Series:Медицинский совет
Subjects:
ulcerative colitis
uc
5-asa
mesalazine
mesacol
sulfasalazine
infliximab
relapse
remission
Online Access:https://www.med-sovet.pro/jour/article/view/2076

Internet

https://www.med-sovet.pro/jour/article/view/2076

Similar Items